Related Experiment Video
Updated: Jun 4, 2025
08:02
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
Engineering Modular Peptide Nanoparticles for Ferroptosis-Enhanced Tumor Immunotherapy
Bihan Wu1, Xuejiao Yang1, Nan Kong1
1Department of Chemistry, School of Science, Westlake University Institution Institute of Natural Sciences, Westlake Institute for Advanced Study, No. 600 Dunyu Road, Hangzhou, 310024, Zhejiang Province, China.
Angewandte Chemie (International Ed. in English)
|December 25, 2024
Summary
Engineered nanoparticles combine ferroptosis induction and immunotherapy to overcome tumor immunosuppression. This approach enhances T cell activity and promotes tumor growth regression, offering a promising cancer treatment strategy.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Immunotherapy
Background:
- Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors show promise for cancer treatment but face challenges due to the immunosuppressive tumor microenvironment.
- Developing effective cancer therapies requires strategies to overcome tumor-induced immune suppression.
Purpose of the Study:
- To engineer a modular peptide-based nanoparticle system for enhanced cancer immunotherapy.
- To integrate ferroptosis induction and PD-L1 antagonism within a single nanoparticle platform.
- To optimize therapeutic outcomes by modulating the tumor microenvironment and enhancing anti-tumor immunity.
Main Methods:
- Development of an orchestrated nanoparticle system using modular peptide assemblies with specific binding domains.
- Co-assembly of a hydrophobic ferroptosis precursor, an IDO1 inhibitor, and a hydrophilic PD-L1 antagonist.
- Evaluation of nanoparticle-induced immunogenic ferroptosis, T lymphocyte function, regulatory T cell suppression, and tumor growth regression.
Main Results:
- The engineered nanoparticles successfully induced immunogenic ferroptosis.
- Enhanced intratumoral T lymphocyte function and suppression of regulatory T cells were observed.
- Effective modulation of the immunosuppressive tumor microenvironment led to significant tumor growth regression.
Conclusions:
- The modular peptide-based nanoparticle platform offers a versatile strategy for cancer therapy.
- Combining ferroptosis and immunotherapy via nanoparticles effectively overcomes tumor immunosuppression.
- This approach holds significant potential for advancing cancer treatment by enhancing anti-tumor immune responses.
